http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16230219

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
issn 2053-3624
issueIdentifier 2
pageRange e000908-
publicationName Open Heart
startingPage e000908
bibliographicCitation Sandhu RK, Ezekowitz JA, Hijazi Z, Westerbergh J, Aulin J, Alexander JH, Granger CB, Halvorsen S, Hanna MS, Lopes RD, Siegbahn A, Wallentin L. Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial. Open Heart. 2018 Nov;5(2):e000908. doi: 10.1136/openhrt-2018-000908.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9afd58f8f928e6e66bab149d1edcb73
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f8cae243db7d69d614a5e5c12507102
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_734a07b93738e9e9b9c14e1b48684623
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2724-4086
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7420-743X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e9c6c2caf8cbfba9690d4f6e730151b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c43848a698f5fbe84e56171fdf0a48e8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_539a5d0d0da11a424f1ee70b1d6244b9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b91f8eca8ac3be6aaabf1d440967af4e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e516432d659e3182c7f5887e7b017119
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cda1a5555356569965216160c3dd1c9f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_498d9a1945a0fb3856a0b684207a8d2e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d1ebecab0560546a75e571efa5822035
date 201811
identifier https://pubmed.ncbi.nlm.nih.gov/PMC6242013
https://pubmed.ncbi.nlm.nih.gov/30487982
https://doi.org/10.1136/openhrt-2018-000908
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/42517
https://portal.issn.org/resource/ISSN/2053-3624
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10182969
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7920
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10897
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_db534dfb811794dcf8169959477d8ea5
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b9e9e853ec37090889fc73d55388409f
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7559
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8679
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e1ebee15383515c47d0a6f1347140469
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54678486
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8235
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6994

Showing number of triples: 1 to 46 of 46.